Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection. [electronic resource]
Producer: 20120522Description: 421-6 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- adverse effects
- Antiviral Agents -- adverse effects
- Boronic Acids -- adverse effects
- Bortezomib
- Comorbidity
- Endemic Diseases
- Female
- Hepatitis B -- epidemiology
- Humans
- Immunologic Factors -- adverse effects
- Incidence
- Lamivudine -- adverse effects
- Male
- Middle Aged
- Multiple Myeloma -- epidemiology
- Prevalence
- Prospective Studies
- Pyrazines -- adverse effects
- Retrospective Studies
- Risk Factors
- Secondary Prevention
- Stem Cell Transplantation -- adverse effects
- Transplantation, Autologous
- Virus Activation -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.